Nothing Special   »   [go: up one dir, main page]

MX2015005235A - Metodo para reducir trigliceridos. - Google Patents

Metodo para reducir trigliceridos.

Info

Publication number
MX2015005235A
MX2015005235A MX2015005235A MX2015005235A MX2015005235A MX 2015005235 A MX2015005235 A MX 2015005235A MX 2015005235 A MX2015005235 A MX 2015005235A MX 2015005235 A MX2015005235 A MX 2015005235A MX 2015005235 A MX2015005235 A MX 2015005235A
Authority
MX
Mexico
Prior art keywords
dpa
disclosure relates
reducing triglycerides
reducing
chylomicrons
Prior art date
Application number
MX2015005235A
Other languages
English (en)
Inventor
Andrew Sinclair
Original Assignee
Univ Deakin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Deakin filed Critical Univ Deakin
Publication of MX2015005235A publication Critical patent/MX2015005235A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente descripción se refiere a ácido docosapentanoico (DPA) del tipo omega-3 (DPA 22:5n-3) o derivado del mismo y su uso para reducir hipertrigliceridemia en un sujeto que necesita del mismo. En particular, la descripción se refiere a la capacidad del n-3 DPA para reducir de manera importante la incorporación de ácidos grasos en quilomicrones en el ámbito postprandial.
MX2015005235A 2012-10-23 2013-10-23 Metodo para reducir trigliceridos. MX2015005235A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261717157P 2012-10-23 2012-10-23
PCT/AU2013/001225 WO2014063190A1 (en) 2012-10-23 2013-10-23 Method for reducing triglycerides

Publications (1)

Publication Number Publication Date
MX2015005235A true MX2015005235A (es) 2015-12-03

Family

ID=50543773

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015005235A MX2015005235A (es) 2012-10-23 2013-10-23 Metodo para reducir trigliceridos.

Country Status (8)

Country Link
US (1) US20150258050A1 (es)
EP (1) EP2911657A4 (es)
JP (1) JP2016500055A (es)
KR (1) KR20150098611A (es)
AU (1) AU2013334478A1 (es)
CA (1) CA2889238A1 (es)
MX (1) MX2015005235A (es)
WO (1) WO2014063190A1 (es)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US7070970B2 (en) * 1999-08-23 2006-07-04 Abbott Laboratories Elongase genes and uses thereof
GB0301701D0 (en) * 2003-01-24 2003-02-26 Ensay Ltd Psoriasis and Eicosapentaenoic acid
FR2878747B1 (fr) * 2004-12-03 2007-03-30 Pierre Fabre Medicament Sa Utilisation d'acide(s) gras omega-3 pour le traitement de l'hypercholesterolemie causee par un traitement anti-retroviral chez les patients infectes par le vih
CN1951399B (zh) * 2005-10-18 2010-12-01 天津贝特药业有限公司 一种海狗油的分子蒸馏制备方法
SI3318255T1 (sl) * 2009-06-15 2021-07-30 Amarin Pharmaceuticals Ireland Limited Kompozicije in metode za zdravljenje kapi pri subjektu, ki prejema sočasno zdravljenje s statinom
WO2011060492A1 (en) * 2009-11-18 2011-05-26 The University Of Sydney Combination for treating metabolic disorders
EP3583849A1 (en) * 2010-03-04 2019-12-25 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating and/or preventing cardiovascular disease
WO2012038833A1 (en) * 2010-09-24 2012-03-29 Pronova Biopharma Norge As Process for concentrating omega-3 fatty acids
CN101978951A (zh) * 2010-11-16 2011-02-23 王京南 Dpa酯脂肪乳静脉注射液及制造方法
JP2014505731A (ja) * 2011-02-16 2014-03-06 ピヴォタル セラピューティクス インコーポレイテッド 心血管疾患のリスク因子を治療するための、ＥＰＡ、ＤＨＡおよびＤＰＡを含むω３製剤
US20120302639A1 (en) * 2011-02-16 2012-11-29 Pivotal Therapeutics Inc. Omega 3 formulations for treatment of risk factors for cardiovascular disease and protection against sudden death
EP2734197A4 (en) * 2011-07-21 2014-12-17 Dsm Ip Assets Bv FATTY ACID COMPOSITIONS
CN104321055A (zh) * 2012-01-06 2015-01-28 翁特拉制药公司 游离酸形式的ω-3多不饱和脂肪酸的富含dpa组合物

Also Published As

Publication number Publication date
JP2016500055A (ja) 2016-01-07
CA2889238A1 (en) 2014-05-01
US20150258050A1 (en) 2015-09-17
AU2013334478A1 (en) 2015-05-21
KR20150098611A (ko) 2015-08-28
WO2014063190A1 (en) 2014-05-01
EP2911657A4 (en) 2016-08-03
EP2911657A1 (en) 2015-09-02

Similar Documents

Publication Publication Date Title
MY165048A (en) Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
MX2016008270A (es) Lipido que comprende acidos grasos poliinsaturados de cadena larga.
PH12016500216B1 (en) Stable pharmaceutical composition and methods of using same
ZA201502764B (en) Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
ZA201308469B (en) Nutritional compositions including branched chain fatty acids and methods of using same
ZA201308606B (en) Nutritional compositions having alpha-hica and eicosapentaenoic acid
WO2014004861A3 (en) Methods of treating pediatric metabolic syndrome
EP3022310A4 (en) Microorganisms and methods for the production of fatty acids and fatty acid derived products
MX2014000770A (es) Composiciones de acidos grasos.
SG11201501013PA (en) Microorganisms and methods for the production of fatty acids and fatty acid derived products
AU2018256637A1 (en) Brassica rod1 gene sequences and uses thereof
HK1205645A1 (en) Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids rrr-
EP3030248A4 (en) Tall oil fatty acid for use in treatment and animal feed supplements and compositions
WO2014165190A3 (en) Compositions comprising docosapentaenoic acid and methods of use
EP3027180A4 (en) Compositions and methods of the treatment of fatty acid metabolism disorders
MX2015005235A (es) Metodo para reducir trigliceridos.